Driss F, Zarski J P, Courouce A M, Eme D, Brechot C, Berthelot P, Tron F, Nalpas B
Service d'Hépato-Gastroentérologie, Hôpital Laennec, Paris.
Gastroenterol Clin Biol. 1991;15(6-7):477-80.
The significance of isolated anti-HBs antibodies in subjects not vaccinated against the hepatitis B virus (HBV) was investigated in 13 healthy blood donors. All were European and none had any risk factor for hepatitis B infection. Serological assays included HBV-DNA and anti-preS 2 antibody determinations which were all negative. After injection with hepatitis B vaccine (Hevac B), only one out of the 13 subjects exhibited an anamnestic response in favor of secondary immunization. Neutralization tests for serum anti-HBs antibody were positive in only 6 subjects. Our data suggest that in most cases isolated anti-HBs positivity does not correspond to true antibody; booster injection of HBV vaccine seems to be the best way of verifying that antibodies are really protective.
在13名健康献血者中研究了未接种乙肝病毒(HBV)疫苗的个体中分离出的抗-HBs抗体的意义。所有献血者均为欧洲人,且均无乙肝感染的危险因素。血清学检测包括HBV-DNA和抗前S2抗体测定,结果均为阴性。注射乙肝疫苗(Hevac B)后,13名受试者中只有1人表现出有利于二次免疫的回忆反应。血清抗-HBs抗体的中和试验仅在6名受试者中呈阳性。我们的数据表明,在大多数情况下,分离出的抗-HBs阳性并不对应于真正的抗体;加强注射乙肝疫苗似乎是验证抗体是否真正具有保护性的最佳方法。